Evolent Health
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $652,520 | $496,246 | $468,719 | $479,533 |
Gross Profit | 80,836 | 61,919 | 52,216 | 75,859 |
EBITDA | 12,776 | 13,632 | -366,761 | 23,313 |
EBIT | -8,790 | -8,854 | -411,798 | -3,483 |
Net Income | -28,364 | -26,632 | -429,131 | -20,864 |
Net Change In Cash | 652,520 | 496,246 | 468,719 | 479,533 |
Free Cash Flow | -23,551 | -7,390 | 41,039 | 6,850 |
Cash | 115,703 | 166,005 | 151,856 | 116,650 |
Basic Shares | 112,542 | 111,905 | 114,208 | 114,066 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $1,876,229 | $2,554,741 | $1,963,896 | $1,352,013 |
Gross Profit | 284,032 | 367,353 | 460,470 | 316,584 |
EBITDA | -361,313 | 84,854 | -24,785 | 43,746 |
EBIT | -477,164 | -38,314 | -148,200 | -46,505 |
Net Income | -534,510 | -61,623 | -113,040 | -19,164 |
Net Change In Cash | 1,876,229 | 2,554,741 | 1,963,896 | 1,352,013 |
Cost of Revenue | -139,127 | |||
Free Cash Flow | 4,755 | -6,128 | 113,837 | -49,914 |
Cash | 151,856 | 104,203 | 192,825 | 188,200 |
Basic Shares | 114,208 | 114,682 | 111,251 | 93,699 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.11 |
2026-03-31 | -$0.02 |
2025-12-31 | $0.08 |
2025-09-30 | $0.05 |